Page last updated: 2024-10-20

pyridoxal phosphate and Pancreatic Diseases

pyridoxal phosphate has been researched along with Pancreatic Diseases in 7 studies

Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.

Pancreatic Diseases: Pathological processes of the PANCREAS.

Research Excerpts

ExcerptRelevanceReference
"Caroli's disease is a rare congenital disorder first described by Caroli in 1958."1.36Magnetic resonance cholangiography with mangafodipir trisodium in Caroli's disease with pancreas involvement. ( Camera, L; Fusari, M; Imbriaco, M; Maurea, S; Mollica, C; Salvatore, M, 2010)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maurea, S1
Mollica, C1
Imbriaco, M1
Fusari, M1
Camera, L1
Salvatore, M1
Boraschi, P2
Donati, F2
Volpi, A1
Campori, G1
Gigoni, R1
Caramella, D1
Boggi, U1
Falaschi, F1
Bartolozzi, C1
Rofsky, NM1
Earls, JP1
Kettritz, U1
Semelka, RC1
Wang, C1
Diehl, SJ1
Lehmann, KJ1
Gaa, J1
McGill, S1
Hoffmann, V1
Georgi, M1

Reviews

2 reviews available for pyridoxal phosphate and Pancreatic Diseases

ArticleYear
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Magnetic resonance imaging clinics of North America, 1996, Volume: 4, Issue:1

    Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clini

1996
Contrast-enhanced MR imaging of the pancreas.
    Magnetic resonance imaging clinics of North America, 1996, Volume: 4, Issue:1

    Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mangan

1996

Trials

1 trial available for pyridoxal phosphate and Pancreatic Diseases

ArticleYear
MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
    Investigative radiology, 1999, Volume: 34, Issue:9

    Topics: Adult; Aged; Carcinoma, Ductal, Breast; Chronic Disease; Contrast Media; Diagnosis, Differential; Ed

1999

Other Studies

4 other studies available for pyridoxal phosphate and Pancreatic Diseases

ArticleYear
Magnetic resonance cholangiography with mangafodipir trisodium in Caroli's disease with pancreas involvement.
    JOP : Journal of the pancreas, 2010, Sep-06, Volume: 11, Issue:5

    Topics: Adult; Caroli Disease; Cholangiography; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resona

2010
On the AJR viewbox. Intrapancreatic accessory spleen: diagnosis with RES-specific contrast-enhanced MRI.
    AJR. American journal of roentgenology, 2005, Volume: 184, Issue:5

    Topics: Choristoma; Contrast Media; Diagnosis, Differential; Edetic Acid; Humans; Magnetic Resonance Imaging

2005
Mangafodipir trisodium-enhanced MR imaging of pancreatic disease.
    European radiology, 2006, Volume: 16, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Imag

2006
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Acta radiologica. Supplementum, 1998, Volume: 415

    Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Bar

1998